UFP Technologies, Inc.

NASDAQ:UFPT

Medical - Devices

Healthcare
$305.65 +4.44%

+$10.10 today

Market cap
$2.37B
Beta
1.10
P/E (TTM)
26.8
EPS (TTM)
$8.89
52W Low $173.86High $274.93

Volume 0.08M

Average 0.21M

UFPT Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

UFP Technologies, Inc.NASDAQ: UFPT

Financing Cash Flow · Q2 FY2026 · quarter ended Jun 2026

Financing cash flow growth accelerates

Q2 FY2026 financing cash flow of $25.36M (cash outflow) rose 32.9% year over year, ahead of the -144.5% change in trailing-twelve-month financing cash flow. Sequentially, it rose 1466.4% from the prior quarter. Over 3 fiscal years it compounded at +31.0% a year.

Context

  • Financing cash flow amounted to 9.6% of revenue in FY2025, down 20.6 pp from a year earlier.
  • Financing cash flow increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +32.9% holds above the trailing-twelve-month pace of -144.5%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$25.36M+1466.4% QoQ
Last fiscal yearDec 2025
-$58.16M-138.2% YoY
LTMJun 2026
-$55.35M-144.5% YoY
Financing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+32.9%——
1 year-138.2%——
3-year CAGR+31.0%——
5-year CAGR——
10-year CAGR——

Financing Cash Flow history

USD · from the cash flow

Latest · FY2025
(58.16M) USD
Year-over-year change
-138.2%

Financing Cash Flow vs competitors

How UFPT compares with its peers on the latest reported figures

  • UFPT's LTM Jun 2026 financing cash flow of $55.35M is the 5th largest of the 11 companies compared; the peer median is $1.76M.
  • Its year-over-year change of -144.5% is the 9th highest of 11, against a peer median of -41.2%.
  • Financing cash flow amounts to 8.8% of revenue for UFPT, versus a peer median of 6.9%.
UFPT Competitors Peer median
Financing Cash Flow for UFPT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$3.71B -25.9%-1.4%9.9%
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$883M -224.0%—4.4%
CNMDCONMED CorporationLTM Mar 2026$129.98M -20.0%—9.5%
ENOVEnovis CorporationLTM Apr 2026$77.57M -331.7%-51.7%3.4%
UFPTUFP Technologies, Inc.LTM Jun 2026$55.35M -144.5%+31.0%8.8%
ESTAEstablishment Labs Holdings Inc.LTM Sep 2026$28.87M -73.5%-26.1%10.9%
KIDSOrthoPediatrics Corp.LTM Mar 2026$23.49M -56.4%-43.9%9.7%
SSIISS Innovations International, Inc.LTM Mar 2026$21.92M -24.9%+64.3%45.2%
SIBNSI-BONE, Inc.LTM Mar 2026$3.31M +69.1%+15.4%1.6%
RXSTRxSight, Inc.LTM Mar 2026$2.26M -98.0%-33.5%1.8%
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026$1.26M +101.5%—0.1%
Peer median (excluding UFPT) $1.76M-41.2%-26.1%6.9%

Competitors are the stored peer set for UFPT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income15.89M41.79M44.92M58.98M68.31M
Depreciation & Amortization8.41M11.89M11.41M14.72M19.15M
Deferred Income Tax(1.79M)(4.71M)816K1.33M5.11M
Stock-Based Compensation2.43M3.21M4.64M6.84M8.85M
Change in Working Capital(10.62M)(22.47M)(24.13M)(16.34M)(9.7M)
Accounts Receivables(6.86M)(15.91M)(12.11M)(2.19M)4.79M
Inventory(4.5M)(19.61M)(16.57M)(4.69M)3.9M
Accounts Payables102K9.13M1.55M(1.14M)(1.09M)
Other Working Capital632K3.92M2.99M(8.32M)(17.3M)
Other Non-Cash Items(14K)(11.96M)3.67M1.06M180K
Operating Cash Flow14.29M17.74M41.33M66.59M91.91M
Capital Expenditures(5.4M)(13.78M)(10.49M)(9.66M)(12.93M)
Acquisitions (Net)(96.18M)(20.65M)0(197.48M)(14.72M)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities114K35.72M2K(3.03M)51K
Investing Cash Flow(101.46M)1.29M(10.49M)(210.16M)(27.6M)
Debt Repayment74.81M(20M)(23M)157.3M(53.92M)
Common Stock Issued00680K(4.72M)194K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(761K)(5.83M)(7.7M)(188K)(4.43M)
Financing Cash Flow74.05M(25.89M)(30.02M)152.39M(58.16M)
Effect of Forex Changes0193K(10K)(635K)699K
Net Change in Cash(13.12M)(6.67M)812K8.19M6.85M
Free Cash Flow8.9M3.96M30.84M56.94M78.98M

UFP Technologies, Inc.

NASDAQ:UFPT

Intrinsic Alpha fair value

Locked

Current Price

$305.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.